TWC
VRTX icon

TD Waterhouse Canada’s Vertex Pharmaceuticals VRTX Stock Holding History

TD Waterhouse Canada’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.8M Sell
13,646
-128
-0.9% -$56.7K 0.02% 347
2026
Q1 		$6.14M Buy
13,774
+8,043
+140% +$3.75M 0.02% 346
2025
Q4 		$2.6M Buy
5,731
+134
+2% +$57.8K 0.02% 405
2025
Q3 		$2.26M Sell
5,597
-8,505
-60% -$3.55M 0.01% 423
2025
Q2 		$6.37M Buy
14,102
+4,479
+47% +$2.06M 0.05% 239
2025
Q1 		$4.65M Buy
9,623
+783
+9% +$365K 0.04% 270
2024
Q4 		$3.56M Buy
8,840
+6,386
+260% +$2.96M 0.03% 309
2024
Q3 		$1.15M Buy
2,454
+1,489
+154% +$715K 0.01% 481
2024
Q2 		$455K Sell
965
-4,330
-82% -$1.88M ﹤0.01% 612
2024
Q1 		$2.18M Buy
5,295
+1,043
+25% +$441K 0.02% 380
2023
Q4 		$1.78M Sell
4,252
-1,258
-23% -$465K 0.02% 349
2023
Q3 		$1.99M Buy
5,510
+1,202
+28% +$420K 0.02% 317
2023
Q2 		$1.51M Buy
4,308
+3,152
+273% +$1.06M 0.02% 358
2023
Q1 		$369K Sell
1,156
-1,729
-60% -$519K ﹤0.01% 568
2022
Q4 		$841K Sell
2,885
-8,258
-74% -$2.52M 0.01% 434
2022
Q3 		$4.23M Sell
11,143
-1,390
-11% -$400K 0.05% 206
2022
Q2 		$4.56M Sell
12,533
-22
-0.2% -$5.89K 0.05% 207
2022
Q1 		$4.11M Sell
12,555
-16,737
-57% -$3.97M 0.04% 237
2021
Q4 		$6.53M Buy
+29,292
New +$5.7M 0.06% 183

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

TD Waterhouse Canada's VRTX Position: Q2 2026 in Review

TD Waterhouse Canada reduced its Vertex Pharmaceuticals (VRTX) stake by 0.93% in Q2 2026, selling an estimated $56.7K and leaving 13,646 shares worth $6.8M. The position accounts for 0.02% of the portfolio, ranked #347.

TD Waterhouse Canada first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • TD Waterhouse Canada held 13,646 shares of Vertex Pharmaceuticals worth $6.8M as of Q2 2026.
  • TD Waterhouse Canada sold 128 Vertex Pharmaceuticals shares in Q2 2026, an estimated $56.7K.
  • Vertex Pharmaceuticals made up 0.02% of TD Waterhouse Canada's portfolio in Q2 2026, its #347 holding.
  • TD Waterhouse Canada first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.